Alessandra DAbramo
Overview
Explore the profile of Alessandra DAbramo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1094
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vita S, Bartoli T, Mariano A, Maffongelli G, Scorzolini L, Corpolongo A, et al.
Travel Med Infect Dis
. 2025 Jan;
64:102804.
PMID: 39874995
No abstract available.
2.
Colavita F, Carletti F, DAbramo A, Nicastri E, Maggi F
Lancet Infect Dis
. 2024 Dec;
25(1):e11-e12.
PMID: 39653052
No abstract available.
3.
Vita S, Lalle E, Caputi P, Faraglia F, DAbramo A, Bordi L, et al.
Travel Med Infect Dis
. 2024 Sep;
62:102762.
PMID: 39306188
Background: Since August to November 2023, 82 cases of autochthonous or non-travel related Dengue virus (DENV) infection have been reported in Italy, highlighting a concerning trend of local transmission. We...
4.
Sberna G, Rozera G, Minosse C, Bordi L, Mazzotta V, DAbramo A, et al.
Emerg Infect Dis
. 2024 Aug;
30(9):1829-1833.
PMID: 39127126
The 2022 global mpox outbreak was driven by human-to-human transmission, but modes of transmission by sexual relationship versus sexual contact remain unclear. We evaluated sexual transmission of mpox by using...
5.
Vergori A, Matusali G, Cimini E, Bordi L, Borrelli P, Lanini S, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066422
. We aimed to report the real-world use and outcomes over time in immunocompromised individuals receiving tixagevimab/cilgavimab (T/C) pre-exposure prophylaxis (PrEP). . This observational study included participants who received T/C...
6.
Lalle E, Mazzotta V, Sberna G, Fabeni L, Garbuglia A, Mastrorosa I, et al.
Viruses
. 2024 Jul;
16(7).
PMID: 39066203
Despite emerging evidence indicating that molecular SARS-CoV-2 tests performed on saliva have diagnostic sensitivity and specificity comparable to those observed with nasopharyngeal swabs (NPSs), most in vivo follow-up studies on...
7.
Vita S, Giombini E, De Marco P, Rueca M, Gruber C, Beccacece A, et al.
Mediterr J Hematol Infect Dis
. 2024 Jun;
16(1):e2024043.
PMID: 38882452
No abstract available.
8.
Tomassi M, DAbramo A, Vita S, Corpolongo A, Vulcano A, Bartoli T, et al.
Malar J
. 2024 Apr;
23(1):93.
PMID: 38575935
Background: Plasmodium ovale malaria is usually considered a tropical infectious disease associated with low morbidity and mortality. However, severe disease and death have previously been reported. Case Presentation: A case...
9.
Cozzi-Lepri A, Borghi V, Rotundo S, Mariani B, Ferrari A, Borgo C, et al.
Front Med (Lausanne)
. 2024 Mar;
11:1293431.
PMID: 38529120
Introduction: Casirivimab and imdevimab (CAS/IMV) are two non-competing, high-affinity human IgG1 anti-SARS-CoV-2 monoclonal antibodies, that showed a survival benefit in seronegative hospitalized patients with COVID-19. This study aimed to estimate...
10.
DAbramo A, Vita S, Beccacece A, Navarra A, Pisapia R, Fusco F, et al.
Front Med (Lausanne)
. 2024 Mar;
11:1344267.
PMID: 38487021
Objectives: The aim of the study was to describe a cohort of B-cell-depleted immunocompromised (IC) patients with prolonged or relapsing COVID-19 treated with monotherapy or combination therapy. Methods: This is...